Nikhil Kamath

795 total citations · 1 hit paper
11 papers, 544 citations indexed

About

Nikhil Kamath is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Surgery. According to data from OpenAlex, Nikhil Kamath has authored 11 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Nikhil Kamath's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Nikhil Kamath is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Nikhil Kamath collaborates with scholars based in United Kingdom, United States and Germany. Nikhil Kamath's co-authors include Piotr Kuna, James L. Zazzali, Rob G. Stirling, Dennis K. Ledford, Karin Rosén, Thilo Jakob, Allen P. Kaplan, Mark Ashby, William Berger and Joachim Veith and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Heart Rhythm.

In The Last Decade

Nikhil Kamath

10 papers receiving 536 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

2013 392 citations Allen P. Kaplan, Dennis K. Ledford et al. Journal of Allergy and Clinical Immunology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Nikhil Kamath	380	248	235	94	81	11	544
William Berger	393 1.0×	239 1.0×	236 1.0×	71 0.8×	71 0.9×	15	590
Abdelkader Rahmaoui	345 0.9×	193 0.8×	201 0.9×	277 2.9×	158 2.0×	8	590
Mary S. Bradley	365 1.0×	196 0.8×	208 0.9×	356 3.8×	200 2.5×	10	681
Stefan Cimbollek	109 0.3×	85 0.3×	257 1.1×	30 0.3×	29 0.4×	22	383
Paolo Delvino	128 0.3×	71 0.3×	54 0.2×	35 0.4×	13 0.2×	30	328
B Hamrin	179 0.5×	24 0.1×	61 0.3×	18 0.2×	20 0.2×	8	300
Carole Guillet	38 0.1×	30 0.1×	17 0.1×	25 0.3×	11 0.1×	21	193
Annica Nordin	79 0.2×	165 0.7×	10 0.0×	16 0.2×	4 0.0×	18	294
U. Specks	91 0.2×	31 0.1×	78 0.3×	142 1.5×	10 0.1×	9	322
Dimitrios Christidis	183 0.5×	24 0.1×	66 0.3×	50 0.5×	8 0.1×	9	313

Countries citing papers authored by Nikhil Kamath

Since Specialization

Citations

This map shows the geographic impact of Nikhil Kamath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Kamath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Kamath more than expected).

Fields of papers citing papers by Nikhil Kamath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Kamath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Kamath. The network helps show where Nikhil Kamath may publish in the future.

Co-authorship network of co-authors of Nikhil Kamath

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Kamath. A scholar is included among the top collaborators of Nikhil Kamath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Kamath. Nikhil Kamath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kamath, Nikhil, et al.. (2025). Emergency laparoscopic cholecystectomy for gall bladder volvulus presenting as acute abdomen in an octogenarian: A case report. Journal of Minimal Access Surgery. 22(1). 79–82.

Kamath, Nikhil, et al.. (2025). A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes. Journal of Addictive Diseases. 44(1). 83–87. 1 indexed citations

Richeldi, Luca, Courtney Schiffman, Jürgen Behr, et al.. (2024). Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial. American Journal of Respiratory and Critical Care Medicine. 209(9). 1132–1140. 17 indexed citations

Kamath, Nikhil, et al.. (2023). Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective. Therapeutic Advances in Respiratory Disease. 17. 2683760865–2683760865. 5 indexed citations

Raghu, Ganesh, Mark J. Hamblin, Alison Brown, et al.. (2022). Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study. Respiratory Research. 23(1). 129–129. 25 indexed citations

Szefler, Stanley J., Graham Roberts, Adalberto Sperb Rubin, et al.. (2022). Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS). Clinical and Translational Allergy. 12(7). e12176–e12176. 22 indexed citations

Richeldi, Luca, Kevin J. Anstrom, Jürgen Behr, et al.. (2021). Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study. PA461–PA461. 1 indexed citations

Sultan, Pervez, Nikhil Kamath, Brendan Carvalho, et al.. (2020). Evaluation of inpatient postpartum recovery using the Obstetric Quality of Recovery-10 patient-reported outcome measure: a single-center observational study. American Journal of Obstetrics & Gynecology MFM. 2(4). 100202–100202. 46 indexed citations

Corren, Jonathan, Nicola A. Hanania, Phillip E. Korenblat, et al.. (2016). Rapid Lung Function Improvement with Lebrikizumab in Patients with Uncontrolled Asthma. Journal of Allergy and Clinical Immunology. 137(2). AB13–AB13. 2 indexed citations

10.

Kaplan, Allen P., Dennis K. Ledford, Mark Ashby, et al.. (2013). Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. Journal of Allergy and Clinical Immunology. 132(1). 101–109. 392 indexed citations breakdown →

11.

Kamath, Nikhil, Mehul Dhinoja, Dominic J. Abrams, et al.. (2009). Cryoablation versus radiofrequency ablation for treatment of atrioventricular nodal reentrant tachycardia: Cryoablation with 6-mm-tip catheters is still less effective than radiofrequency ablation. Heart Rhythm. 7(3). 340–343. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact